NxStage Completes Final Closing of Previously Announced Private Placement of Common Stock
NxStage will use proceeds of the private placement financing to advancefurther the commercialization of its products and the development of newproducts for its product pipeline. The Company also intends to use theproceeds for general corporate purposes.
NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company,headquartered in Lawrence, Massachusetts, USA, that develops, manufactures andmarkets innovative products for the treatment of ESRD and acute kidneyfailure. For more information on NxStage and its products, please visit thecompany's website at www.nxstage.com.
This release contains "forward-looking statements" within the meaning ofthe Private Securities Litigation Reform Act of 1995. All statements containedin this release that are not clearly historical in nature are forward-looking,and the words "anticipate," "believe," "expect," "estimate," "plan," andsimilar expressions are generally intended to identify forward-lookingstatements. Examples of these forward-looking statements include statements asto the anticipated use of the private financing proceeds. All forward-lookingstatements involve risks, uncertainties and contingencies, many of which arebeyond NxStage's control, which may cause actual results, performance, orachievements to differ materially from anticipated results, performance orachievements, including certain factors that may affect future operatingresults and which are detailed in NxStage's filings with the Securities andExchange Commission, including the Quarterly Report on Form 10- Q for theperiod ended March 31, 2008.
In addition, the statements in this press release represent NxStage'sexpectations and beliefs as of the date of this press release. NxStageanticipates that subsequent events and developments may cause theseexpectations and beliefs to change. However, while NxStage may elect to updatethese forward-looking statements at some point in the future, it specificallydisclaims any obligation to do so, whether as a result of new information,future events, or otherwise. These forward-looking statements should not berelied upon as representing NxStage's expectations or beliefs as of any datesubsequent to the date of this press release.Contact: Kristen K. Sheppard, Esq. VP, Investor Relations email@example.com
SOURCE NxStage Medical, Inc.
You May Also Like